Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
International Journal of Chronic Obstructive Pulmonary Disease|October 3, 2018
Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPDEdward M Kerwin, Robert Tosiello, Barry Price, et al.
Medical and Pediatric Oncology|January 1, 1984
Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinomaR E Waldhorn, E Tsou, F P Smith, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 29, 2021
A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium TherapyGary T Ferguson, Edward M Kerwin, Tara Rheault, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 29, 2018
Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPDColin Reisner, James Pearle, Edward M Kerwin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 6, 2019
ELLIPTA Dry Powder Versus Metered-Dose Inhalers in an Optimized Clinical Trial SettingEdward M Kerwin, Andrew Preece, Dimitra Brintziki, et al.
Respiratory Research|July 31, 2019
Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized studyEdward M Kerwin, Gary T Ferguson, Mindy Mo, et al.
COPD|October 2, 2012
Efficacy of indacaterol 75 μg once-daily on dyspnea and health status: results of two double-blind, placebo-controlled 12-week studiesMark H Gotfried, Edward M Kerwin, David Lawrence, et al.
Journal of Medicinal Chemistry|October 23, 1998
Design of new topoisomerase II inhibitors based upon a quinobenzoxazine self-assembly modelQ Zeng, Y Kwok, S M Kerwin, et al.
Acta Anatomica|January 1, 1992
Nerve growth factor receptor-like immunoreactivity in the human spinal cordJ M Kerwin, C M Morris, R H Perry, et al.
Neuroscience Letters|August 31, 1992
Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's diseaseJ M Kerwin, C M Morris, R H Perry, et al.
Pageof 16